Haibo Shen

9PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 25, 2024
Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.

Huangqi Duan, Yu Shen, Chen Wang

|Mar 24, 2023
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.

Chen Wang, Qifeng Cao, Shun Zhang

|Jan 21, 2022
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8<sup>+</sup> T cells in bladder cancer.

Weimin Xia, Shun Zhang, Huangqi Duan

|Dec 01, 2021
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.

Shun Zhang, Cheng Wang, Weimin Xia

|Apr 16, 2021
Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study.

Subo Qian, Shun Zhang, Weimin Xia

|Jun 09, 2020
Urinary kidney injury molecule-1: a novel biomarker to monitor renal function in patients with unilateral ureteral obstruction.

Subo Qian, Weimin Xia, Yu Wu

Pageof 2

Frequent Collaborators

2 joint publications

Jun Qi

2 joint publications

Subo Qian

2 joint publications

Chen Wang

1 joint publications

Yu Wu